Molecular Pharmacology & Chemistry Program

The goals of the Molecular Pharmacology and Chemistry Program include the conception, design, and synthesis of new anticancer and antiviral agents; elucidation of mechanisms of action and resistance of anticancer agents; preclinical evaluation and toxicology of promising new agents; translational research bearing on radiation and chemotherapy; risk assessment of new therapies; and broader aspects of cancer etiology, prevention, and pathogenesis.

The program functions as a conduit for bringing discoveries in the basic biological sciences - generated from cancer-related molecular pharmacology and from the other research programs - to preclinical and clinical evaluation. More than half of our researchers are engaged in laboratory-associated clinical investigation.